{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Xu X"],"funding":["Shanghai Municipal Health Commission","National Natural Science Foundation of China"],"pagination":["e188"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9634586"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8(6)"],"pubmed_abstract":["<h4>Background</h4>Benzodiazepine receptor agonists (BZRAs) are commonly used clinically and data on their hazardous use from large populations of psychiatric patients is limited.<h4>Aims</h4>To assess the current status of hazardous BZRA use and related factors in Chinese out-patient psychiatric settings.<h4>Method</h4>The study included out-patients with at least one BZRA prescription from five psychiatric settings in east, central and west China in 2018. Demographic and prescription information were extracted from the electronic prescription database. We defined the co-occurrence of overdose and long-term use as hazardous use, and patients whose recorded diagnoses did not meet any indications approved by the Chinese Food and Drug Administration as over-indication users. Additionally, 20"],"journal":["BJPsych open"],"pubmed_title":["Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: electronic prescription database study."],"pmcid":["PMC9634586"],"funding_grant_id":["20184Y0134","82171485","82171483"],"pubmed_authors":["Zhong N","Zhao M","Li C","Jiang H","Wang G","Wang W","Chen Y","Wang X","Xu X","Ye Y","Liu T","Xu J"],"additional_accession":[]},"is_claimable":false,"name":"Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: electronic prescription database study.","description":"<h4>Background</h4>Benzodiazepine receptor agonists (BZRAs) are commonly used clinically and data on their hazardous use from large populations of psychiatric patients is limited.<h4>Aims</h4>To assess the current status of hazardous BZRA use and related factors in Chinese out-patient psychiatric settings.<h4>Method</h4>The study included out-patients with at least one BZRA prescription from five psychiatric settings in east, central and west China in 2018. Demographic and prescription information were extracted from the electronic prescription database. We defined the co-occurrence of overdose and long-term use as hazardous use, and patients whose recorded diagnoses did not meet any indications approved by the Chinese Food and Drug Administration as over-indication users. Additionally, 20","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-22T09:56:47.644Z","creation":"2025-04-05T23:16:07.438Z"},"accession":"S-EPMC9634586","cross_references":{"pubmed":["36254807"],"doi":["10.1192/bjo.2022.589"]}}